Your browser doesn't support javascript.
loading
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab.
Zhang, Hangyu; Yuan, Liyun; Liu, Lulu; Yan, Cong; Cheng, Jinming; Fu, Qihan; Tong, Zhou; Jiang, Weiqin; Zheng, Yi; Zhao, Peng; Zhang, Guoqing; Fang, Weijia.
Afiliación
  • Zhang H; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Yuan L; National Genomics Data Center, Bio-Med Big Data Center, CAS-MPG Partner Institute for Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, People's Republic of China.
  • Liu L; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Yan C; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Cheng J; National Genomics Data Center, Bio-Med Big Data Center, CAS-MPG Partner Institute for Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, People's Republic of China.
  • Fu Q; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Tong Z; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Jiang W; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Zheng Y; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Zhao P; Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, China.
  • Zhang G; Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • Fang W; National Genomics Data Center, Bio-Med Big Data Center, CAS-MPG Partner Institute for Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, People's Republic of China. g
BMC Cancer ; 20(1): 416, 2020 May 13.
Article en En | MEDLINE | ID: mdl-32404198
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Genoma Humano / Proteínas Proto-Oncogénicas p21(ras) / Resistencia a Antineoplásicos / Transcriptoma / Cetuximab / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Genoma Humano / Proteínas Proto-Oncogénicas p21(ras) / Resistencia a Antineoplásicos / Transcriptoma / Cetuximab / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article